Published Guidance, NICE advice and quality standards

Skip to filtersSkip to results

Skip to results

Last updated date

Last updated date

Area of interest

Area of interest

Type 1 selected

Type

Guidance programme

Showing 1801 to 1825 of 1861

TitleReference numberPublishedLast updated
Urinary tract infection in under 16s: diagnosis and managementNG224
UroLift for treating lower urinary tract symptoms of benign prostatic hyperplasiaMTG58
UroShield for preventing catheter-associated urinary tract infectionsMTG69
Ustekinumab for moderately to severely active Crohn's disease after previous treatmentTA456
Ustekinumab for the treatment of adults with moderate to severe psoriasisTA180
Ustekinumab for treating active psoriatic arthritisTA340
Ustekinumab for treating moderately to severely active ulcerative colitisTA633
Uterine artery embolisation for fibroidsIPG367
Uterine artery embolisation for treating adenomyosisIPG473
Uterine suspension using mesh (including sacrohysteropexy) to repair uterine prolapseIPG584
Vaccine uptake in the general populationNG218
Vaginal transluminal endoscopic hysterectomy and adnexal surgery for benign gynaecological conditionsIPG774
Vagus nerve stimulation for refractory epilepsy in childrenIPG50
Valve-in-valve TAVI for aortic bioprosthetic valve dysfunctionIPG653
Vandetanib for treating medullary thyroid cancerTA550
Varenicline for smoking cessationTA123
Varicose veins: diagnosis and managementCG168
Vedolizumab for treating chronic refractory pouchitis after surgery for ulcerative colitis (terminated appraisal)TA826
Vedolizumab for treating moderately to severely active Crohn's disease after prior therapyTA352
Vedolizumab for treating moderately to severely active ulcerative colitisTA342
Velmanase alfa for treating alpha-mannosidosisHST29
Vemurafenib for treating locally advanced or metastatic BRAF V600 mutation‑positive malignant melanomaTA269
Venetoclax for treating chronic lymphocytic leukaemiaTA796
Venetoclax with azacitidine for untreated acute myeloid leukaemia when intensive chemotherapy is unsuitableTA765
Venetoclax with low dose cytarabine for untreated acute myeloid leukaemia when intensive chemotherapy is unsuitableTA787

Results per page

  1. 10
  2. 25
  3. 50
  4. All